Control of aminophosphine chelate ring-opening in Pt(II) and Pd(II) complexes: potential dual-mode anticancer agents

Citation
A. Habtemariam et al., Control of aminophosphine chelate ring-opening in Pt(II) and Pd(II) complexes: potential dual-mode anticancer agents, J CHEM S DA, (8), 2001, pp. 1306-1318
Citations number
48
Categorie Soggetti
Inorganic & Nuclear Chemistry
Journal title
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
ISSN journal
14727773 → ACNP
Issue
8
Year of publication
2001
Pages
1306 - 1318
Database
ISI
SICI code
1472-7773(2001):8<1306:COACRI>2.0.ZU;2-V
Abstract
We show that bis(aminophosphine) complexes of the type [M((RRN)-R-1-N-2(CH2 )(n)PPh2)(2)](2+), M = Pt(II) or Pd(II), can exist in chelate ring-closed a nd ring-opened forms both in the solid state and in aqueous solution. The e quilibrium between them in solution can be controlled by the nature of the groups R-1 and R-2 (H, Me, Bz, cyclohexyl), by the bridge length n, and by the pH and Cl- concentration. X-Ray crystal structures are reported for the ring-closed complexes cis-[Pt(H2N(CH2)(2)PPh2-P,N)(2)]Cl-2, cis-[Pt(H2N(CH 2)(3)PPh2-P,N)(2)]Cl-2, and cis-[Pt(Me(H)N(CH2)(2)PPh2-P,N)(2)]Cl-2, the mo no-ring-opened complex cis-Pd[(Me2N(CH2)(2)PPh2-N,P)Cl(Me2NH(CH2)(2)PPh2-P] (NO3)(2), the di-ring-opened complex cis-[Pt(Me2N(CH2)(3)PPh2-P)(2)Cl-2], a nd, for comparison, the monochelate cis-[Pd(Me2N(CH2)(3)PPh2-N,P)]Cl-2. The se square-planar complexes exhibit varying degrees of distortion and variab le M-N bond lengths dependent not only on the trans influence of P but also on steric effects within the complex. pH-induced chelate ring-opening of c is-[Pt(Me2N(CH2)(2)PPh2-P,N)(2)]Cl-2 had an associated pK value of 6.9. In contrast, complexes with R-1 and R-2 = H, n = 2 or 3 or R-1 = H and R-2 = M e, n = 2, are more difficult to ring-open. Thus the complexes cis-[Pt(Me(H) N(CH2)(2)PPh2-P,N)(2)]Cl-2 and cis-[Pt(H2N(CH2)(3)PPh2-P,N)(2)]Cl-2, had as sociated pK values of 2.1 and 2.9, respectively. These aminophosphine compl exes may exhibit anticancer activity by two mechanisms: by disrupting mitoc hondrial membrane potentials as bis-chelated (ring-closed) lipophilic catio ns, or by direct binding to DNA bases as ring-opened complexes.